AIDS Research - Testing, Treatment, Prevention, HIV, Life Expectancy

AIDS Research Today is a free monthly online journal that collates and summarizes the latest research about AIDS, including details on testing, treatment, prevention, hiv, life expectancy.


AIDS Research Today

Home

View Latest Issue

Information About AIDS

Books on AIDS

Advertising in Research Today

View Other Research Today Publications



Volume 2 (2005), Issue 6 (June)

  1. AIDS-related knowledge, attitudes and behavior among adolescents in Zambia.
    AIDS Behav, 9(2): 223-31. [Abstract] [Full-text]
  2. Development of a brief scale to measure AIDS-related stigma in South Africa.
    AIDS Behav, 9(2): 135-43. [Abstract] [Full-text]
  3. Is it possible to reduce AIDS deaths without reinforcing socioeconomic inequalities in health?
    Int J Epidemiol, 34(3): 586-92. [Abstract] [Full-text]
  4. Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in ParanĂ¡, Brazil.
    AIDS Res Hum Retroviruses, 21(4): 256-62. [Abstract] [Full-text]
  5. Regional patterns of the temporal evolution of the AIDS epidemic in Brazil following the introduction of antiretroviral therapy.
    Braz J Infect Dis, 9(1): 9-19. [Abstract] [Full-text]
  6. Discordant molecular characterization results in a Mycobacterium avium complex strain isolated from an AIDS patient.
    J Med Microbiol, 54: 681-3. [Abstract] [Full-text]
  7. HIV/AIDS in women: an expanding epidemic.
    Science, 308(5728): 1582-3. [Abstract] [Full-text]
  8. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome.
    Virology, 337(2): 384-98. [Abstract] [Full-text]
  9. Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors.
    J Virol, 79(13): 8454-69. [Abstract] [Full-text]
  10. In-depth, longitudinal analysis of viral quasispecies from an individual triply infected with late-stage human immunodeficiency virus type 1, using a multiple PCR primer approach.
    J Virol, 79(13): 8249-61. [Abstract] [Full-text]
  11. Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection.
    J Virol, 79(13): 8171-81. [Abstract] [Full-text]
  12. The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use.
    Addiction, 100(7): 990-1002. [Abstract] [Full-text]
  13. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
    Addiction, 100(7): 981-9. [Abstract] [Full-text]
  14. Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection.
    J Infect Dis, 192(2): 303-10. [Abstract] [Full-text]
  15. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.
    J Exp Med, 201(12): 1999-2010. [Abstract] [Full-text]
  16. Complementary therapies for the treatment of HIV: in search of the evidence.
    Int J STD AIDS, 16(6): 395-403. [Abstract] [Full-text]
  17. Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1.
    Infect Immun, 73(7): 4155-60. [Abstract] [Full-text]
  18. Genotypic distribution of human herpesvirus-8 strains circulating in HIV-positive patients with and without Kaposi's sarcoma in Hungary.
    Arch Virol, 150(7): 1315-26. [Abstract] [Full-text]
  19. Disclosing concerns of Latinas living with HIV/AIDS.
    J Transcult Nurs, 16(3): 210-7. [Abstract] [Full-text]
  20. Different epidemic potentials of the HIV-1B and C subtypes.
    J Mol Evol, 60(5): 598-605. [Abstract] [Full-text]
  21. Brazil and access to HIV/AIDS drugs: a question of human rights and public health.
    Am J Public Health, 95(7): 1110-6. [Abstract] [Full-text]
  22. A critical analysis of the Brazilian response to HIV/AIDS: lessons learned for controlling and mitigating the epidemic in developing countries.
    Am J Public Health, 95(7): 1162-72. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 AIDS Research Today. All Rights Reserved.



AIDS Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)



AIDS Books

Fade to Black

Fade to Black